Imfinzi plus Imjudo recommended for approval in the EU by CHMP for advanced liver and lung cancers
Positive opinions based on significant survival benefit
Positive opinions based on significant survival benefit
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Shandong Meditech Medical Technology is a manufacturer of onsite oxygen solutions for the healthcare market.
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Subscribe To Our Newsletter & Stay Updated